Using AI and patient data to create better diagnostics and precision medicines for complex chronic diseases
Join us for a deep dive into finding better, more personalized diagnostic and treatment options for people with unmet medical needs.
This event is a rare opportunity to hear from the CEO of clinical-stage precision medicine company, PrecisionLife, about informing drug discovery, de-risking clinical development, and driving precision medicine in complex chronic diseases that account for over 80% of healthcare costs.
Not knowing which patients will respond to which treatments is a major cause of drug development risk and healthcare inefficiency. To overcome this, PrecisionLife has completely reimagined how to analyze patient data. In this session you’ll discover how to better understand and use causal biology of complex diseases, achieve mechanistic patient stratification, and translate unique insights into clinical practice for more accurate diagnosis and treatment selection.
Sign up to learn more about a new era of precision medicine for chronic diseases and increasing the probability of success from concept to clinic.
Professor and serial entrepreneur Carl Borreback will introduce the speaker and the topic.
About Steve Gardner, CEO & Co-founder of PrecisionLife
Steve is a serial technology entrepreneur with over 30 years’ experience developing and commercializing ground-breaking data science and informatics in the healthcare, life sciences and agri-food sectors, with an established track record in building world-class companies, teams and products.
He is Chair of the UK Bioindustry Association’s Genomic Advisory Committee, Co-Chair of the Metrodora Foundation Scientific Advisory Board, a former Global Director of Research Informatics for Astra A/B, and has consulted with drug discovery and safety teams in over 20 biopharma companies.
PrecisionLife is a pioneering causal AI precision medicine company changing the way the world predicts, prevents, and treats complex, chronic diseases by finding better, more personalized diagnostic and treatment options for patients.